Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,116) with videos related to
Page
of 112
Sort By:
Nature Biotechnology
|
October 27, 2022
Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution
Qing Dai, Li-Sheng Zhang, Hui-Lung Sun, et al.
The Review of Scientific Instruments
|
November 7, 2012
Density fluctuation measurements using beam emission spectroscopy on Heliotron J
S Kobayashi, S Kado, T Oishi, et al.
Leukemia
|
March 21, 2012
Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors
A Ikegame, S Ozaki, D Tsuji, et al.
ESMO Open
|
June 26, 2026
Association of TP53 gain-of-function mutations with early osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma
R Ibusuki, E Iwama, A Shimauchi, et al.
Leukemia
|
May 3, 2014
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma
M Hiasa, J Teramachi, A Oda, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression
K Morimoto, T Yamada, N Furuya, et al.
Nature Cell Biology
|
July 13, 2021
ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing
Li-Sheng Zhang, Qing-Ping Xiong, Sonia Peña Perez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer
H Yoshioka, N Katakami, H Okamoto, et al.
Toxicologic Pathology
|
February 24, 2018
Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert Workshop
B Lenz, A Braendli-Baiocco, J Engelhardt, et al.
Nature Cell Biology
|
August 30, 2018
m<sup>6</sup>A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
Jun Liu, Mark A Eckert, Bryan T Harada, et al.
Page
of 112
Search research articles
Search
Showing results (1101-1110 of 1,116) with videos related to
Sort By:
Page
of 112
Nature Biotechnology
|
October 27, 2022
Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution
Qing Dai, Li-Sheng Zhang, Hui-Lung Sun, et al.
The Review of Scientific Instruments
|
November 7, 2012
Density fluctuation measurements using beam emission spectroscopy on Heliotron J
S Kobayashi, S Kado, T Oishi, et al.
Leukemia
|
March 21, 2012
Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors
A Ikegame, S Ozaki, D Tsuji, et al.
ESMO Open
|
June 26, 2026
Association of TP53 gain-of-function mutations with early osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma
R Ibusuki, E Iwama, A Shimauchi, et al.
Leukemia
|
May 3, 2014
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma
M Hiasa, J Teramachi, A Oda, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression
K Morimoto, T Yamada, N Furuya, et al.
Nature Cell Biology
|
July 13, 2021
ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing
Li-Sheng Zhang, Qing-Ping Xiong, Sonia Peña Perez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer
H Yoshioka, N Katakami, H Okamoto, et al.
Toxicologic Pathology
|
February 24, 2018
Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert Workshop
B Lenz, A Braendli-Baiocco, J Engelhardt, et al.
Nature Cell Biology
|
August 30, 2018
m<sup>6</sup>A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
Jun Liu, Mark A Eckert, Bryan T Harada, et al.
Page
of 112